TrialAdvances in therapy2025

Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study.

Olivier Sitbon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.